POSTDOCTORAL rheumatology researcher Dr Paul Koshy has joined Newcastle market research firm Marketwise Strategies to help grow its work in the healthcare sector.
Paul, 35, from Newcastle, completed his PhD in Rheumatology at Newcastle University in 2000, carrying out research into arthritis.
Previously he completed a BSc in Medical Biochemistry at Brunel University in London, where he worked on research projects ranging from osteoporosis research at the Royal London Hospital to cancer work at the Institute of Cancer Research in Surrey.
Paul has also worked in industry, testing the biocompatibility of a new medical engineering product.
After a spell in Germany working on a church leadership programme, Paul has joined the seven-strong Marketwise Strategies team after being introduced by one of the firm’s clients.
He is now delivering proof of concept research for an innovative new medical device and has already carried out research for a potential spin-out from Newcastle University. Paul, who also gets married this month, said: “Marketwise Strategies has an excellent reputation for its research and strategy support to technology-based businesses.
It is increasingly active in healthcare markets and in this role I can use my science background to really make a difference to the North East’s healthcare businesses.”
Marketwise Strategies’ managing director, Jacquie Potts said: “Most of our researchers are PhD or masters qualified in their chosen field, and Paul brings a vast amount of experience to our healthcare research projects. We are delighted to welcome him on board.”